BRAF mutation appears to be associated with distinct, unfavourable clinicopathological characteristics in colorectal cancer.
No takes yet. Share an insight, caveat, or question.
Clancy et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: